Grand Rapids, MINCT07076082Now EnrollingIRB Ready

Peripheral Arterial Disease Clinical Trial in Grand Rapids, MI

Access cutting-edge peripheral arterial disease treatment through this clinical trial at a research site in Grand Rapids. Study-provided care at no cost to qualified participants.

Sponsored by Corewell Health West

Quick Self-Assessment

See if you qualify for this Grand Rapids location

Preparing your pre-screening questions…

Expert Care in Grand Rapids

Access peripheral arterial disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related peripheral arterial disease treatment provided free

Apply for This Grand Rapids Location

Check if you qualify for this peripheral arterial disease clinical trial in Grand Rapids, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Grand Rapids

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Grand Rapids site if eligible
  4. 4Begin participation

About This Peripheral Arterial Disease Study in Grand Rapids

The purpose of this investigator-initiated, multicenter, open label, randomized trial is to evaluate 1 month vs. 6 months of dual antiplatelet therapy (DAPT) in patients undergoing lower extremity endovascular revascularization. We hypothesize that extending dual antiplatelet therapy (DAPT) to six months, compared to one month, will improve patency rates of target vessels following peripheral vascular intervention (PVI) without significantly increasing complications, particularly bleeding events.

Sponsor: Corewell Health West

Who Can Participate

Inclusion Criteria

Age greater than or equal to 45 at time of enrollment
Patient is scheduled for a PVI or has recently had a PVI in the last 30 days
Patient data is being submitted to Fivos, who is acting as the data collection subcontractor for the VQI-PVI registry.
Atherosclerotic vascular disease

Exclusion Criteria

Patients who cannot consent for themselves
Allergy to Clopidogrel
Patients unable to stop clopidogrel for other medical reasons
Patients on dual pathway inhibition (DPI) with low dose rivaroxaban (2.5mg twice a day) that are unable to stop these medications
Allergy to aspirin
Nonatherosclerotic vascular disease
Patients undergoing open bypass at the same time as the peripheral transcutaneous angioplasty
Patients with high bleeding risk (HBR) defined as:
History of major bleeding, active bleeding disorder, severe renal impairment (CrCl \<30), concurrent anticoagulation, platelet count \<100,000
Recent stroke (within 6 months)
Current warfarin therapy or full dose therapeutic direct oral anticoagulants (DOAC).
Patients unwilling or unable to comply with standard of care follow-up visits
Pregnant women

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Grand Rapids?

Yes, this clinical trial (NCT07076082) has an active research site in Grand Rapids, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Peripheral Arterial Disease Treatment Options in Grand Rapids, MI

If you're searching for peripheral arterial disease treatment options in Grand Rapids, MI, this clinical trial (NCT07076082) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Grand Rapids research site is actively enrolling participants for this clinical trial. You'll receive care from experienced peripheral arterial disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all peripheral arterial disease clinical trials near you to find additional studies recruiting in your area.

More Peripheral Artery Disease Trials in Grand Rapids, MI

See all peripheral artery disease clinical trials recruiting in Grand Rapids — not just this study.

Browse Peripheral Artery Disease Trials in Grand Rapids

Ready to Join in Grand Rapids?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Grand Rapids, MI